MedTrace Logo

PRECISION GRX Registry

NCT03278301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 952

Last updated 2020-10-19

No results posted yet for this study

Summary

To collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath GRX System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters, and manipulation of guide catheters during PCI procedures.

Conditions

Interventions

DEVICE

Robotic-assisted PCI

The CorPath GRX is intended for use in the remote delivery and manipulation of guidewires and rapid exchange balloon/stent catheters, and remote manipulation of guide catheters during percutaneous coronary intervention (PCI) procedures.

Sponsors & Collaborators

  • Corindus Inc.

    lead INDUSTRY

Principal Investigators

  • Ehtisham Mahmud, MD · University of California, San Diego

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-27
Primary Completion
2020-02-06
Completion
2020-02-06

Countries

  • United States
  • Brazil
  • India
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03278301 on ClinicalTrials.gov